We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

126 hedge funds and large institutions have $1.57B invested in ChemoCentryx, Inc. in 2019 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 38 increasing their positions, 37 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

557% more capital invested

Capital invested by funds: $239M → $1.57B (+$1.33B)

159% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 17

60% more call options, than puts

Call options by funds: $40.6M | Put options by funds: $25.4M

26% more funds holding

Funds holding: 100126 (+26)

3% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 37

Holders
126
Holders Change
+26
Holders Change %
+26%
% of All Funds
2.48%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.12%
New
44
Increased
38
Reduced
37
Closed
17
Calls
$40.6M
Puts
$25.4M
Net Calls
+$15.2M
Net Calls Change
+$14.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$8.77M -$6.2M -353,293 -61%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$8.21M +$498K +28,389 +16%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$7.78M -$1.6M -91,000 -32%
LGM
29
Logos Global Management
California
$7.37M +$3.27M +186,238 New
EA
30
Emerald Advisers
Pennsylvania
$6.85M +$3.04M +173,220 New
EMFAT
31
Emerald Mutual Fund Advisers Trust
Pennsylvania
$6.48M +$2.88M +163,926 New
Invesco
32
Invesco
Georgia
$6.41M +$199K +11,357 +8%
FCM
33
Frontier Capital Management
Massachusetts
$5.98M +$2.65M +151,144 New
AA
34
ALPS Advisors
Colorado
$4.64M +$20.7K +1,179 +1%
CM
35
Caption Management
Oklahoma
$4.6M +$903K +51,401 +79%
American Century Companies
36
American Century Companies
Missouri
$4.55M +$2.02M +115,098 New
EI
37
EAM Investors
California
$4.36M +$1.93M +110,139 New
DMK
38
David M. Knott
$4.2M +$1.77M +101,075 +2,022%
Charles Schwab
39
Charles Schwab
California
$3.97M +$63.5K +3,616 +4%
Morgan Stanley
40
Morgan Stanley
New York
$3.63M -$1.02M -58,142 -39%
T. Rowe Price Associates
41
T. Rowe Price Associates
Maryland
$3.62M +$1.61M +91,600 New
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$3.49M -$3.14M -178,921 -67%
AllianceBernstein
43
AllianceBernstein
Tennessee
$3.49M +$507K +28,850 +49%
WG
44
Winton Group
United Kingdom
$3.44M +$1.26M +71,509 +463%
EGI
45
EAM Global Investors
California
$3.31M +$1.47M +83,610 New
AI
46
Atom Investors
Texas
$3.29M +$1.46M +83,156 New
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$2.93M +$491K +27,974 +61%
Allianz Asset Management
48
Allianz Asset Management
Germany
$2.9M +$1.29M +73,195 New
Swiss National Bank
49
Swiss National Bank
Switzerland
$2.86M +$316K +18,000 +33%
EAM
50
Erste Asset Management
Austria
$2.46M +$1.19M +68,000 New

CCXI Hedge Fund Activity: Q4 2019 in Review

126 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2019, worth a combined $1.57B — up 557% from $239M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new CCXI positions and 17 closed out — a net gain of 27 holders — while 38 added to existing stakes and 37 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $56.2M. The largest seller was Carmignac Gestion, cutting an estimated $40.6M.

  • 126 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2019, up from 100 in Q3 2019.
  • Funds reported $1.57B of ChemoCentryx, Inc. stock for Q4 2019, up 557% quarter-over-quarter.
  • 44 funds opened new ChemoCentryx, Inc. positions in Q4 2019 and 17 closed out, a net change of +27 holders.
  • The largest ChemoCentryx, Inc. buyer in Q4 2019 was RA Capital Management, an estimated $56.2M added.
  • The largest ChemoCentryx, Inc. seller in Q4 2019 was Carmignac Gestion, an estimated $40.6M sold.

Based on aggregated 13F filings for Q4 2019.